Early targeted therapy improves outcomes in generalized MG, study suggests
A study found that adding targeted therapies within 24 months of a gMG diagnosis leads to better daily function and a higher quality of life.
Lucia Rajcic
Master of Pharmacy (MPharm) with a strong background in clinical practice and pharmaceutical sciences. Dedicated to providing accurate, evidence-based medical content for healthcare professionals and patients.
